Based on these characteristics, CTLA4-immunoglobulin (Ig), namely abatacept, selectively blocks CD28 co-stimulation and defends against potentially autoreactive T cells, thereby preventing T1D (7, 103, 132). The gene discussed is CTLA4; the disease is type 1 diabetes mellitus.